Literature DB >> 7783051

Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation.

P Koolwijk1, A M Miltenburg, M G van Erck, M Oudshoorn, M J Niedbala, F C Breedveld, V W van Hinsbergh.   

Abstract

OBJECTIVE: To evaluate the occurrence of gelatinase-B (matrix metalloproteinase 9, MMP-9) in synovial fluids (SF) of patients with arthritis to investigate the possible role of this neutral MMP in joint destruction.
METHODS: In paired (series I) and unpaired SF (series II) we examined the occurrence of gelatinase-B, prostromelysin-1, and urokinase-type plasminogen activator (u-PA).
RESULTS: In the paired SF a parallelism between the presence of activated gelatinase-B and the local arthritis activity scores of the knees was observed. Activated gelatinase-B correlated well with the presence of stromelysin-1 and u-PA, 2 enzymes probably involved in the activation process of gelatinase-B. In the 2nd series, activated gelatinase-B was found in 56 SF samples, whereas 82 samples did not exhibit activated gelatinase-B. The SF samples with the activated form of gelatinase-B showed a significantly higher ability to induce permeability changes in cultured monolayers of human endothelial cells, had more myeloperoxidase activity--secreted by infiltrated leukocytes--and had higher u-PA antigen concentrations, compared to SF samples without the activated form of gelatinase-B.
CONCLUSION: Our data suggest that the presence of gelatinase-B is a reflection of the inflammatory condition of the joints of patients with arthritis, and that the activation of gelatinase-B in the joints, which may occur in a u-PA/plasmin dependent and/or a stromelysin dependent way, contributes to the progression of arthritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783051

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  Experimental Arthritis Is Dependent on Mouse Mast Cell Protease-5.

Authors:  Richard L Stevens; H Patrick McNeil; Lislaine A Wensing; Kichul Shin; G William Wong; Philip M Hansbro; Steven A Krilis
Journal:  J Biol Chem       Date:  2017-02-13       Impact factor: 5.157

2.  Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

3.  Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

Review 4.  Clinical potential of matrix metalloprotease inhibitors in cancer therapy.

Authors:  E I Heath; L B Grochow
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 5.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

6.  Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.

Authors:  Min-Hua Sun; Xi-Chun Han; Ming-Ku Jia; Wei-Dong Jiang; Min Wang; Hong Zhang; Gang Han; Yi Jiang
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

7.  Temporospatial expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in mouse antigen-induced arthritis.

Authors:  Kirsi Joronen; Veli-Matti Kähäri; Eero Vuorio
Journal:  Histochem Cell Biol       Date:  2005-08-27       Impact factor: 4.304

8.  Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases.

Authors:  David M Thompson; Hsi-Ming Lee; Julie A Stoner; Lorne M Golub; Pirkka V Nummikoski; Jeffrey B Payne
Journal:  J Periodontal Res       Date:  2019-04-29       Impact factor: 4.419

9.  Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease.

Authors:  E H Burns; A M Marciel; J M Musser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

10.  Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.